상단으로
Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
The Korean Society of Pathologists 2011
May 12, 2011
The Korean Society of Pathologists 2011 was held at the Seoul Education Culture Center from May 12 -13. Seegene presented its BRAF somatic mutation detection test.
This BRAF mutation (V600E) uses thyroid tissue from papillary thyroid carcinoma and detects the relevant BRAF gene mutation by PCR-based Molecular Diagnostics. The detection of V600E allows for an early diagnosis of suspected Thyroid cancer and can also be utilized in monitoring the status of the patient after the surgery.
This BRAF mutation (V600E) uses thyroid tissue from papillary thyroid carcinoma and detects the relevant BRAF gene mutation by PCR-based Molecular Diagnostics. The detection of V600E allows for an early diagnosis of suspected Thyroid cancer and can also be utilized in monitoring the status of the patient after the surgery.